Search results for " biopharmaceutical" in Articles / App Notes
Article
Automating the Biomanufacturing Process
Automation implementation
For more than 15 years, biopharmaceutical manufacturers have been implementing automation and control systems, both upstream and downstream, says Christoph Lebl, head of …
Article
A Plastic Pipeline for Commercial Bioprocessing?
BioPlan Associates, 15th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, 2018.
4. ABEC, “ABEC Increases the Maximum Capacity of Its Custom Single Run (CSR) B…
Article
Automation Trend in Fill/Finish Reduces Contamination Risk
By Feliza Mirasol
Aseptic filling is a crucial process in biopharmaceutical manufacturing because it has a potential safety impact on the end user and because aseptic filling is a highly tec…
Article
3rd BioProcessing Asia Preview: Q&A with John Curling
…ked a forum for a science and technology-focused discussion on best practices for the development of biopharmaceuticals. We founded BioProcessing Asia to enable scientists from academia and industry,…
Article
Managing Residual Impurities During Downstream Processing
There is, however, no set of standard assays for the determination of contaminants such as HCPs during manufacturing because each biopharmaceutical process is unique and results in unique impurities; …
Article
Automating Bioprocesses
By Jennifer Markarian
Both upstream and downstream biopharmaceutical processes have conventionally used stainless-steel equipment, but use of single-use systems (SUS) is becoming more established.…
Article
Biopharma in 2016: Higher Quality Drugs, Less Expensive Manufacturing
The global biopharmaceuticals market was valued at $162 billion in 2014 and pre¬dicted by Persistence Market Research to grow at a compound annual growth rate of 9.4% from 2014 to 2020 to reach $278 b…
Article
Perfusion in the 21st Century
By Bruce Lehr, Delia Lyons
Cell-culture technology for biopharmaceutical manufacturing has steadily advanced over the past three decades. Batch processing, in which all raw materials are introduce…
Article
Managing Biomanufacturing Capacity Expectations
According to a new survey by BioPlan Associates, more than half of respondents (60%) expect facility constraints to create biopharmaceutical production capacity constraints by 2021 (1). BioPlan found …
Article
Going Small to Achieve Success on the Commercial Scale
Scale-down models are used in the development of nearly every unit operation in the overall biopharmaceutical manufacturing process, including both upstream and downstream steps, and separation and fi…